Technavio Releases Key Highlights for Their Upcoming Organ Transplant Immunosuppressant, Fetal Monitoring Devices, and Cryosurgery Devices Reports

Technavio's healthcare and life sciences report library covers a variety of industries. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--Technavio’s research analysts have recently completed numerous reports analyzing the latest market opportunities, trends, and developments in the global healthcare and life sciences industry. Per Technavio's recent market findings, the progression of the healthcare industry towards efficient and cost-effective healthcare solutions has had a huge impact on the medical devices, life sciences, and pharmaceutical sectors.

Technavio has compiled a list of three markets that have high growth potential for the forecast period of 2017-2021. All three of these reports are currently available at a USD 1,000 discount for a limited time only. To access all of Technavio’s reports request a free demo to see how you can view the full library which consists of 8,000+ reports.

Key Highlights from Technavio

Global Organ Transplant Immunosuppressant Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • Genzyme, Allergan, AbbVie, BMS, Sanofi, Novartis, Astellas, Roche, and Pfizer are some of the important vendors in the global organ transplant immunosuppressant market.
  • The increasing cases of organ transplants and advancement in technology may influence the demand for organ transplant immunosuppressant in the coming years.
  • This report also considers the growth of the related markets such as the botanical and plant-derives drugs market, which is expected to grow at a CAGR of nearly 8% during the forecasted period.

Global Fetal Monitoring Devices Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • The market is divided into internal and external fetal monitoring devices, with the former occupying the dominant shares.
  • The rising focus of various governments on providing prenatal care is a key factor driving the growth of the global fetal monitoring devices market.
  • This report also considers the growth of the similar markets such as the pulse oximetry, which is expected to grow at a CAGR of above 5% during the forecasted period.

Global Cryosurgery Devices Market 2017-2021

This report is available at a USD 1,000 discount: View market snapshot before purchasing

  • Rising volume of oncological surgeries is one of the important growth drivers of the global cryosurgery devices market.
  • Manufacturers are undertaking R&D through clinical trials to prove the efficiency of non-invasive surgeries to the population, which is expected to drive innovations of cryosurgery devices over the forecast period.
  • This report also considers the growth of the similar markets such as the urology surgery supplies, which is expected to grow at a CAGR of above 10% during the forecasted period.

Access Technavio’s Full Report Library

Technavio subscription plans start at USD 10,000 annually. Subscribing to this plan will give you immediate access to new reports as they’re published in addition to all 8,000+ existing reports in 120+ industries and 50+ countries. Request a free demo to learn more about this offer.

Browse other reports from our healthcare and life sciences library:

About Technavio

Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

Release Summary

Technavio announces highlights and figures from their upcoming organ transplant immunosuppressant, fetal monitoring devices, and cryosurgery devices reports.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com